Yoshihito Mima

15PUBLICATIONS
2CO-AUTHORS
AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicinePowder and particle technologyRural and regional geography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 16, 2026
Letter: The Retrospective Analysis of the Association Between Longitudinal Thymus and Activation-regulated Chemokine Changes and Cutaneous Adverse Events in Patients with Prurigo Nodularis Treated with Nemolizumab.

|Jun 24, 2026
The Impact of Nemolizumab Treatment on the Systemic Inflammatory Indices in Patients With Prurigo Nodularis: A Retrospective Study With a Small Sample Size.

|Jun 22, 2026
Real-world Clinical Efficacy and Patient-reported Treatment Satisfaction of Nemolizumab Treatment in Prurigo Nodularis.

|May 22, 2026
Dupilumab Can Be Effective for Immune-Related Adverse Event Dermatitis: A Case Report and Review of the Literature.

|Oct 16, 2025
Review of Promising Off-Label Use of Deucravacitinib.

Yoshihito Mima, Masako Yamamoto, Ken Iozumi

|Sep 12, 2025
Transient Elevation of Eosinophil and Thymus and Activation-Regulated Chemokine Levels Associated with Cutaneous Adverse Events Due to Nemolizumab: A Case Report.

Yoshihito Mima, Masako Yamamoto, Ken Iozumi

Pageof 3

Frequent Collaborators

5 joint publications

Yuta Norimatsu

1 joint publications

Ken Iozumi